MRNA

Moderna, Inc.

About MRNA

Moderna, Inc. is a biotechnology company. The Company is focused on developing messenger ribonucleic acid (mRNA) therapeutics and vaccines. It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range spectrum of diseases. The Company's products include Spikevax, the Moderna COVID-19 vaccine (mRNA-1273), a bivalent vaccine targeting the BA.1 Omicron variant, combined with Spikevax (mRNA-1273.214), and bivalent vaccine targeting the BA.4/BA.5 Omicron variants combined with Spikevax (mRNA-1273.222). It has a development pipeline of 45 development candidates across its 48 development programs, of which 38 are in clinical studies.

Buy US stocks in Australia starting with MRNA. Open an account and start investing today!

Market Capitalisation

$58.66B

Price-earnings ratio

Dividend yield

0.00%

Volume

617

High today

$153.68

Low today

$148.07

Open price

$0.00

52-week high

$217.25

52-week low

$115.03

MRNA FAQs

How much is one share of Moderna, Inc.?

One share of Moderna, Inc. is valued at $148.53.

What is the ticker symbol for Moderna, Inc.?

The ticker symbol for Moderna, Inc. is MRNA.

How do I buy MRNA shares in Australia?

To buy MRNA stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in MRNA

What is the 52-week high for Moderna, Inc. stock?

The Moderna, Inc. 52-week high stock price is $217.25.

What is the 52-week low for Moderna, Inc. stock?

The Moderna, Inc. 52-week low stock price is $115.03.

What is the market capitalisation of Moderna, Inc. MRNA?

As of 23/03/2023 Moderna, Inc. has a market cap of $59B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.